Trial · NCT03205995
Adverse events78
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 78
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | KIDNEY TRANSPLANT REJECTION | Immune system disorders | OMS721 (Narsoplimab) | 1 | 6 | 3 |
| other | ARTERIOVENOUS FISTULA SITE INFECTION | Infections and infestations | OMS721 (Narsoplimab) | 2 | 6 | 2 |
| other | BACTERIAL INFECTION | Infections and infestations | OMS721 (Narsoplimab) | 1 | 6 | 1 |
| other | CLOSTRIDIUM DIFFICILE INFECTION | Infections and infestations | OMS721 (Narsoplimab) | 1 | 6 | 1 |
| other | INFECTION | Infections and infestations | OMS721 (Narsoplimab) | 2 | 6 | 2 |
| other | MOLLUSCUM CONTAGIOSUM | Infections and infestations | OMS721 (Narsoplimab) | 1 | 6 | 1 |
| other | RENAL GRAFT INFECTION | Infections and infestations | OMS721 (Narsoplimab) | 1 | 6 | 1 |
| other | UREAPLASMA INFECTION | Infections and infestations | OMS721 (Narsoplimab) | 1 | 6 | 1 |
| other | URINARY TRACT INFECTION ENTEROCOCCAL | Infections and infestations | OMS721 (Narsoplimab) | 1 | 6 | 1 |
| other | ARTERIOVENOUS FISTULA ANEURYSUM | Injury, poisoning and procedural complications | OMS721 (Narsoplimab) | 1 | 6 | 1 |
| other | POST PROCEDURAL HAEMATOMA | Injury, poisoning and procedural complications | OMS721 (Narsoplimab) | 1 | 6 | 1 |
| other | SHUNT BLOOD FLOW EXCESSIVE | Injury, poisoning and procedural complications | OMS721 (Narsoplimab) | 1 | 6 | 2 |
| other | SUBDURAL HAEMATOMA | Injury, poisoning and procedural complications | OMS721 (Narsoplimab) | 1 | 6 | 1 |
| other | BLOOD CHOLESTEROL INCREASED | Investigations | OMS721 (Narsoplimab) | 1 | 6 | 1 |
| other | C-REACTIVE PROTEIN INCREASED | Investigations | OMS721 (Narsoplimab) | 1 | 6 | 1 |
| other | ELECTROCARDIOGRAM QT PROLONGED | Investigations | OMS721 (Narsoplimab) | 1 | 6 | 4 |
| other | HUMAN CHORIONIC GONADOTROPIN ABNORMAL | Investigations | OMS721 (Narsoplimab) | 1 | 6 | 1 |
| other | TREPONEMA TEST POSITIVE | Investigations | OMS721 (Narsoplimab) | 1 | 6 | 1 |
| other | HYPERKALAEMIA | Metabolism and nutrition disorders | OMS721 (Narsoplimab) | 3 | 6 | 9 |
| other | HYPERPHOSPHATAEMIA | Metabolism and nutrition disorders | OMS721 (Narsoplimab) | 2 | 6 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03205995/events?page=2